Smoking increases the requirement for rocuronium

Canadian Journal of Anaesthesia

Volumn 45, Issue 7, 1998, Pages 651-654

  Rautoma, P ^a,b   Svartling, N ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Maria Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ROCURONIUM;

ADOLESCENT; ADULT; ANESTHESIA MECHANISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG METABOLISM; ELECTROMYOGRAM; FEMALE; GENERAL ANESTHESIA; HUMAN; LEG MUSCLE; MALE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING;

EID: 0031661054     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03012095     Document Type: Article

References (12)

1. Dawson GW, Vestal RE. Smoking and drug metabolism. Pharmacol Ther 1982; 15: 207-21.
2. Teiriä H, Rautoma P, Yli-Hankala A. Effect of smoking on dose requirements for vecuronium. Br J Anaesth 1996; 76: 154-5.
3. Wierda JMKH, Kleef UW, Lambalk LM, Kloppenburg WD, Agoston S. The pharmacodynamics and pharmacokinetics of ORG 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl. Can J Anaesth 1991; 38: 430-5.
4. Khuenl-Brady K, Castagnoli KP, Canfell PC, Caldwell JE, Agoston S, Miller RD. The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat. Anesthesiology 1990; 72: 669-74.
5. Meretoja OA, Wirtavuori K. Two-dose technique to create an individual dose-response curve for atraeurium. Anesthesiology 1989; 70: 732-6.
6. Rautoma P, Erkola O, Meretoja OA. Potency and maintenance requirement of atracurium and vecuronium given alone or together. Acta Anaesthesiol Scand 1995; 39: 220-3.
7. Litckfield JT Jr, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949; 53: 99-113.
8. Donlon JV Jr, Savarese JJ, Ali HH, Teplik RS. Human dose-response curves for neuromuscular blocking drugs: a comparison of two methods of construction and analysis. Anesthesiology 1980; 53: 161-6.
9. Meretoja OA, Taivainen T, Brandom BW, Wirtavuori K. Frequency of train-of-four stimulation influences neuromuscular response. Br J Anaesth 1994; 72: 686-7.
10. Taylor P. Agents acting at the neuromuscular junction and autonomic ganglia. In: Goodman Gilman A (Ed.). The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw Hill Inc., 1996: 177-97.
11. Kroeker KA, Beattie WS, Yang H. Neuromuscular blockade in the setting of chronic nicotine exposure. Anesthesiology 1994; 81: A1120.
12. Basta SJ, Ali HH, Savarese JJ, et al. Clinical pharmacology of atracurium besylate (BW 33A): a new non- depolarizing muscle relaxant. Anesth Analg 1982; 61: 723-9.